Phase 1 Relapsed or Refractory Lymphoma Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Clinical Study of U29 Injection (CD30-CART) in Patients With CD30-Positive Relapsed/Refractory Lymphoma

Relapsed or Refractory Lymphoma

Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd18 enrolled1 locationNCT07453446

Recruiting

Phase 1Phase 2

A Phase Ib/II Clinical Study Evaluating the Safety and Efficacy of Tislelizumab in Combination With Golidocitinib and Selinexor for the Treatment of R/R NKTCL

Natural Killer/T-cell LymphomaRelapsed or Refractory Lymphoma Including ENKL

Fudan University68 enrolled1 locationNCT06966154

Recruiting

Phase 1

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

Advanced Solid TumorRelapsed or Refractory Lymphomas

Lantern Pharma Inc.110 enrolled4 locationsNCT06132503